Literature DB >> 18342602

Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.

Umut Ozcan1, Lale Ozcan, Erkan Yilmaz, Katrin Düvel, Mustafa Sahin, Brendan D Manning, Gökhan S Hotamisligil.   

Abstract

Mammalian target of rapamycin, mTOR, is a major sensor of nutrient and energy availability in the cell and regulates a variety of cellular processes, including growth, proliferation, and metabolism. Loss of the tuberous sclerosis complex genes (TSC1 or TSC2) leads to constitutive activation of mTOR and downstream signaling elements, resulting in the development of tumors, neurological disorders, and at the cellular level, severe insulin/IGF-1 resistance. Here, we show that loss of TSC1 or TSC2 in cell lines and mouse or human tumors causes endoplasmic reticulum (ER) stress and activates the unfolded protein response (UPR). The resulting ER stress plays a significant role in the mTOR-mediated negative-feedback inhibition of insulin action and increases the vulnerability to apoptosis. These results demonstrate ER stress as a critical component of the pathologies associated with dysregulated mTOR activity and offer the possibility to exploit this mechanism for new therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342602      PMCID: PMC2361721          DOI: 10.1016/j.molcel.2007.12.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  52 in total

1.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

Authors:  F Urano; X Wang; A Bertolotti; Y Zhang; P Chung; H P Harding; D Ron
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

Review 2.  Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.

Authors:  Yehiel Zick
Journal:  Sci STKE       Date:  2005-01-25

3.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

Review 4.  Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes.

Authors:  Gökhan S Hotamisligil
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 5.  Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Authors:  David J Kwiatkowski; Brendan D Manning
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

6.  Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

Authors:  Leila Khamzina; Alain Veilleux; Sébastien Bergeron; André Marette
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

7.  Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

Authors:  Li Ma; Zhenbang Chen; Hediye Erdjument-Bromage; Paul Tempst; Pier Paolo Pandolfi
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

8.  Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.

Authors:  Brendan D Manning; M Nicole Logsdon; Alex I Lipovsky; Derek Abbott; David J Kwiatkowski; Lewis C Cantley
Journal:  Genes Dev       Date:  2005-07-18       Impact factor: 11.361

Review 9.  Growing roles for the mTOR pathway.

Authors:  Dos D Sarbassov; Siraj M Ali; David M Sabatini
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

Review 10.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

View more
  224 in total

Review 1.  GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.

Authors:  Michal Marzec; Davide Eletto; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2011-11-03

Review 2.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

3.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

4.  mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

5.  PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation.

Authors:  Jun Sun; Crystal S Conn; Yan Han; Vincent Yeung; Shu-Bing Qian
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

6.  Structural determinants of PERK inhibitor potency and selectivity.

Authors:  Hong Wang; Jaime Blais; David Ron; Timothy Cardozo
Journal:  Chem Biol Drug Des       Date:  2010-12       Impact factor: 2.817

Review 7.  Oncogenes strike a balance between cellular growth and homeostasis.

Authors:  Bo Qiu; M Celeste Simon
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

Review 8.  Unfolded protein response signaling and metabolic diseases.

Authors:  Jaemin Lee; Umut Ozcan
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 9.  PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.

Authors:  Vera P Krymskaya; Elena A Goncharova
Journal:  Cell Cycle       Date:  2009-02-06       Impact factor: 4.534

10.  The effects of endoplasmic reticulum stress response on duck decorin stimulate myotube hypertrophy in myoblasts.

Authors:  Lingli Sun; Kai Lu; Hehe Liu; Haohan Wang; Xinxin Li; Chao Yang; Liang Li; Jiwen Wang
Journal:  Mol Cell Biochem       Date:  2013-02-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.